Interpretation of the glaucoma "landmark studies"

British Journal of Ophthalmology

Volumn 93, Issue 5, 2009, Pages 561-562

  Wishart, Peter K ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; ANTIHYPERTENSIVE AGENT;

CATARACTOGENESIS; DISEASE COURSE; EDITORIAL; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RISK FACTOR; TRABECULECTOMY; VISUAL FIELD; DRUG EFFECT; GLAUCOMA; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 66149124136     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.145532     Document Type: Editorial

References (24)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
2. Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
3. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:490-1.
4. Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53.
5. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressure. Am J Ophthalmol 1998;126:487-97.
6. Weinreb RN, Khaw PT. Seminar. Primary open-angle glaucoma. Lancet 2004;363:1711-20.
7. AGIS Investigators. The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 2001;119:1771-9.
8. Musch DC, Gillespie BW, Niziol LM, et al. Collaborative Initial Glaucoma Treatment Study Group. Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol 2006;124:1694-700.
9. Stamper RL, Lieberman MF, Drake MV, eds. Becker- Shaffer's diagnosis and therapy of the glaucomas, 7th edn. St Louis, Missouri, USA: Mosby, 1999: 2.
10. Leske MC, Heijl A, Hussein M, et al. Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;12:48-56.
11. AGIS investigators. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 1994;101:1445-55.
12. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Advanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-35.
13. Collaborative Normal-Tension Study Group.The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
14. Wilson MR, Kosoko O, Cowan CL Jr, et al. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol 2002;134:399-405.
15. Sommer A, Tielsch JM, Katz J. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
16. GLT research group. Glaucoma Laser trial (GLT) and Glaucoma Laser Trial Follow-up Study: 7. Results. Am J Ophthalmol 1995;120:718- 31.
17. Nemesure B, Honkanea, Hennis A, et al.Barbados Eye Studies Group. Incident open-angle glaucoma and intraocular pressure. Ophthalmology 2007;114:1810-15.
18. Hitchings RA, Migdal CS, Wormald R, et al. The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry. Eye 1994;8:117-20.
19. Parc CE, Johnson DH, Oliver JE, et al. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 2001;132:27-35.
20. Chen P. Blindness in patients with treated open- angle glaucoma. Ophthalmology 2003;110:726-33
21. Ehrnrooth P, Puska P, Lehton I, et al. Progression of visual field defects and visual loss in trabeculectomized eyes. Graefes Arch C/in Exp Ophthalmol 2005;243:741-7.
22. Eid TM, Spaeth GL, Bitterman A, et al. Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years. Ophthalmology 2003;110:900-7.
23. Martinez-BelldC, Chauhan BC, Nicolela MT, et al. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol 2000;129:302-8.
24. Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open- angle glaucoma. Ophthalmology 1999;106:997-1004.